https://www.alphaspread.com/security/nyse/abbv/summary
Abbvie Inc (NYSE:ABBV) Intrinsic Valuation. Check if ABBV is overvalued or undervalued under the bear, base, and bull scenarios of the company's future.
fundamental analysisabbvvaluationincalpha
https://careers.abbvie.com/it
Unisciti alla nostra Talent Community
chifalaabbvie
https://www.calicolabs.com/press/abbvie-and-calico-announce-second-extension-of-collaboration-focused-on-aging-and-age-related-diseases/
Jul 30, 2021
abbviecalicoannouncesecondextension
https://careers.abbvie.com/zh-hant
加入我們的人才社群
abbvie
https://careers.abbvie.com/tr
Yetenek Topluluğumuza Katılın
earamatr
https://www.greatplacetowork.co.uk/resources/how-pharma-giant-abbvie-holds-leaders-accountable-for-culture
Learn how AbbVie fosters a high-trust culture by holding leaders accountable for behaviours that drive sustained performance and employee engagement.
pharmagiantabbvieholdsleaders
https://cuonda.com/voces-abbvie/activate-contra-la-ar-ejercicio-y-calidad-de-vida
Sólo un 35% de los pacientes con enfermedades reumáticas alcanzan los mínimos de actividad física recomendados por la OMS. En este podcast, exploramos el
contralaarejerciciocalidad
https://www.calicolabs.com/press/calico-and-abbvie-share-update-on-early-stage-clinical-programs/
Feb 3, 2021 - Companies advancing programs in immuno-oncology and neurodegeneration currently in Phase I studies.
early stageclinical programscalicoabbvieshare
https://www.statnews.com/2025/11/13/biotech-news-fda-outlines-gene-editing-pathway/
Nov 13, 2025 - Today's biotech news covers an FDA pathway for bespoke gene editing, Uniqure CEO blasting FDA turmoil behind closed doors, and more.
fdacrisprcalicoabbvienewsletter
https://greatplacetowork.ie/certified-organisations/abbvie-ireland?hsLang=en
Discover why AbbVie Ireland is Great Place To Work Certified. Explore their workplace culture and find out what employees say about what it's like to work at...
workingabbvieirelandgreatplace
https://careers.abbvie.com/fr-ca
Joignez-vous à notre communauté de talents
ladonneabbviefrca
https://www.statista.com/statistics/417030/revenue-of-abbvie/?__sso_cookie_checker=failed
This statistic illustrates the revenue of AbbVie from 2010 to 2024.
abbvierevenuestatista
https://cuonda.com/voces-abbvie
Un podcast de AbbVie que da voz a historias y perspectivas sobre salud y ciencia.
vocesabbviemdash
https://greatplacetowork.fi/sertifioidut/abbvie/
Jan 3, 2025 - AbbVie on Great Place To Work -sertifioitu työpaikka! Tutustu AbbVien työntekijäkokemukseen ja kulttuuriin GPTW:n sivuilla.
abbviegreatplacework
https://www.greatplacetowork.pt/empresas-certified/biotecnologia-farmaceutico/abbvie
AbbVie // Empresa Certified™ GPTW®
abbviegreatplaceportugal
https://www.wochenblatt-reporter.de/ludwigshafen/c-wirtschaft-handel/ludwigshafen-profitiert-vom-pharma-boom-im-westen-abbvie-baut-forschungszentrum_a694340
Dec 31, 2025 - Ludwigshafen. Der zügige Baufortschritt ist dem neuen Forschungsgebäude von AbbVie anzusehen. Der Pharmariese wird es wie eine Raumstation taufen – Luna...
ludwigshafenvompharmaboomim
https://coinmarketcap.com/currencies/abbvie-tokenized-stock-ondo/
The live AbbVie Tokenized Stock (Ondo) price today is $215.65 USD with a 24-hour trading volume of $531,561.83 USD. We update our ABBVon to USD price in...
abbvietokenizedstockondoprice
https://greatplacetowork.se/organisation?id=106742225366
AbbVie är ett forskande biopharmaföretag som arbetar för att utveckla innovativa behandlingar och hållbara vårdlösningar...
abbvie
https://careers.abbvie.com/pl
Dołącz do naszej społeczności talentów
naabbviepl
https://www.pharmaceuticalprocessingworld.com/abbvie-70m-rs-biologics-manufacturing-rd/
Oct 2, 2025 - AbbVie (NYSE:ABBV) announced that it began construction for a $70 million expansion of its bioresearch center (ABC) in Worcester, Mass.
abbvieubiologicsramp
https://careers.abbvie.com/nl
Word lid van onze Talenten Community
gezochtabbvienl
https://www.statnews.com/2025/11/12/abbvie-calico-layoffs/
Nov 12, 2025 - The pharma giant is severing a collaboration that began in 2014 with a $1.5 billion agreement to find longevity-boosting medicines.
abbviecutstiesgooglebacked
https://www.greatplacetowork.co.uk/resources/podcast-how-abbvie-lives-company-values-to-drive-great-company-culture
In this podcast, hosted by HR Magazine in partnership with Great Place To Work, we talk to Anna Oliver (HR Director, UK) at AbbVie. Anna shares tips on...
abbvieembedslivesvalues
https://www.bnnbloomberg.ca/investing/hot-picks/2026/02/18/hot-picks-microsoft-abbvie-and-pnc-highlight-dividend-growth-in-ai/
Feb 18, 2026 - Microsoft, AbbVie and PNC highlighted as dividend large caps tied to AI growth, pharma pipelines and U.S. banking expansion.
large capsdividendmicrosoftabbviepnc
https://www.greatplacetowork.co.uk/certified-company/1333350
Discover why AbbVie is Great Place To Work Certified. Explore their workplace culture and find out what employees say about what it's like to work at AbbVie.
workingabbviegreatplaceuk
https://www.biopharmadive.com/news/abbvie-mavupharma-deal-immuno-oncology-sting/558767/
Acquiring the private group Mavupharma brings AbbVie a small-molecule agent that acts on the so-called STING pathway.
biopharma diveabbviebetsearlyoncology
https://careers.abbvie.com/privacy-policy
We are very sorry, but we cannot find the page you have requested (page not found). Please click below to view all our open roles.Our Roles
foundabbvie
https://fr.benzinga.com/news/france/general/lapprobation-de-la-fda-pour-le-traitement-combine-dabbvie-astrazeneca-pourrait-etablir-une-nouvelle-norme-pour-le-cancer-du-sang-a-croissance-lente/
L'approbation de la FDA pour le traitement combiné d'AbbVie/AstraZeneca pourrait établir une nouvelle norme pour le cancer du sang à croissance lente | %
de lafdapourletraitement
https://www.drugdiscoverytrends.com/are-big-pharma-giants-getting-the-right-roi-on-their-rd-investments-a-visual-exploration/
Mar 12, 2024 - Analyzing the R&D ROI of top pharma companies like Merck, Pfizer, J&J, and AbbVie reveals some concerning trends and future strategies.
bigpharmaamproimerck
https://www.biopharmadive.com/news/roche-abbvie-venclexta-acute-myeloid-leukemia/574680/
Paired with chemotherapy, Venclexta succeeded in a Phase 3 acute myeloid leukemia trial just weeks after falling short in another combination study.
leukemiadrugrocheabbvieextends
https://careers.abbvie.com/es
Únase a nuestra comunidad de talento
sepersonaabbviees